Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 3
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Delta-Omicron recombinant escapes therapeutic antibody neutralization.
Duerr R, Zhou H, Tada T, Dimartino D, Marier C, Zappile P, Wang G, Plitnick J, Griesemer SB, Girardin R, Machowski J, Bialosuknia S, Lasek-Nesselquist E, Hong SL, Baele G, Dittmann M, Ortigoza MB, Prasad PJ, McDonough K, Landau NR, St George K, Heguy A. Duerr R, et al. Among authors: prasad pj. iScience. 2023 Feb 17;26(2):106075. doi: 10.1016/j.isci.2023.106075. Epub 2023 Feb 13. iScience. 2023. PMID: 36844451 Free PMC article.
Delta-Omicron recombinant escapes therapeutic antibody neutralization.
Duerr R, Zhou H, Tada T, Dimartino D, Marier C, Zappile P, Wang G, Plitnick J, Griesemer SB, Girardin R, Machowski J, Bialosuknia S, Lasek-Nesselquist E, Hong SL, Baele G, Dittmann M, Ortigoza MB, Prasad PJ, McDonough K, Landau NR, George KS, Heguy A. Duerr R, et al. Among authors: prasad pj. bioRxiv [Preprint]. 2022 Aug 16:2022.04.06.487325. doi: 10.1101/2022.04.06.487325. bioRxiv. 2022. Update in: iScience. 2023 Feb 17;26(2):106075. doi: 10.1016/j.isci.2023.106075. PMID: 35411351 Free PMC article. Updated. Preprint.
Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19.
Zacharioudakis IM, Prasad PJ, Zervou FN, Basu A, Inglima K, Weisenberg SA, Aguero-Rosenfeld ME. Zacharioudakis IM, et al. Among authors: prasad pj. Ann Am Thorac Soc. 2021 May;18(5):900-903. doi: 10.1513/AnnalsATS.202008-931RL. Ann Am Thorac Soc. 2021. PMID: 33119425 Free PMC article. No abstract available.
Coinfections and antimicrobial use in patients hospitalized with coronavirus disease 2019 (COVID-19) across a single healthcare system in New York City: A retrospective cohort study.
Prasad PJ, Poles J, Zacharioudakis IM, Dubrovskaya Y, Delpachitra D, Iturrate E, Muñoz-Gómez S. Prasad PJ, et al. Antimicrob Steward Healthc Epidemiol. 2022 May 10;2(1):e78. doi: 10.1017/ash.2022.51. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36483377 Free PMC article.
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients.
Ulrich RJ, Troxel AB, Carmody E, Eapen J, Bäcker M, DeHovitz JA, Prasad PJ, Li Y, Delgado C, Jrada M, Robbins GA, Henderson B, Hrycko A, Delpachitra D, Raabe V, Austrian JS, Dubrovskaya Y, Mulligan MJ. Ulrich RJ, et al. Among authors: prasad pj. Open Forum Infect Dis. 2020 Sep 23;7(10):ofaa446. doi: 10.1093/ofid/ofaa446. eCollection 2020 Oct. Open Forum Infect Dis. 2020. PMID: 33134417 Free PMC article.